Viral mimic systems and other tech platforms could enable local testing of vaccine candidates and antiviral therapies. This ...

Future Virology. 2013;8(1):1-2. During the global 2002/2003 SARS pandemic, many foundations, pharmaceutical companies and governments provided abundant funds to support the development of anti-SARS ...

Much research to elucidate potential antigens, routes of vaccination, and methods for the design of SARS vaccines has been completed. Immunogenicity has been widely demonstrated, but identification of ...

The induction of respiratory mucosal immunity, characterized by secretory IgA (sIgA) and lung-resident memory T (TRM) cells, is essential for ...

New mRNA vaccine is more effective and less costly to develop. A new type of mRNA vaccine is more scalable and adaptable to continuously evolving viruses such as SARS-CoV-2 and H5N1, according to a ...